Latest Cancer News
Drinking 2 Sodas A Week Nearly Doubles Risk Of Pancreatic CancerMore bad news for soda-drinkers: A University of Minnesota study suggests that drinking two or more soft drinks a week nearly doubles the risk of developing pancreatic cancer. Mark Pereira, an associate professor at the School of Public Health, and his research team studied the dietary habits of more than 60,000 adults in Singapore for 14 years.
Experts Stress Need For Colon Cancer TestsAbout half of Americans who should be screened for colon cancer aren't tested for the disease, which kills about 50,000 each year and is largely survivable if detected early. An expert panel convened by the National Institutes of Health drew attention yesterday to the shortcomings in the nation's effort to lower colorectal-cancer deaths and recommended improvements.
Scientists Report Research In Pancreatic Cancer TreatmentCurrent study results from the report, 'Feasibility and safety of radiofrequency ablation for locally advanced pancreatic cancer,' have been published. Radiofrequency ablation (RFA) may be a valuable treatment option for locally advanced pancreatic cancer. The present study examined its feasibility and safety, researchers in Verona, Italy report.
Yale University: Cultural Values Influence Perception Of Vaccine's RiskNew research conducted by the Cultural Cognition Project at Yale Law School concludes that people's cultural values influence how risky they perceive the human papillomavirus (HPV) vaccine to be and thus, their views on whether or not the vaccine to prevent the disease should be mandatory for elementary school girls.
Reports Describe Recent Advances In Ovarian CancerThe aim of this study was to explore patients and health professional's perceptions of follow- up service provision following treatment for ovarian cancer. In the United Kingdom, where this study took place, ovarian cancer is the most common gynaecological cancer in women, investigators in Manchester, the United Kingdom report.
Scientists At University Of Verona Report Research In Pancreatic Cancer PreventionCurrent study results from the report, 'Feasibility and safety of radiofrequency ablation for locally advanced pancreatic cancer,' have been published. Radiofrequency ablation (RFA) may be a valuable treatment option for locally advanced pancreatic cancer. The present study examined its feasibility and safety, researchers in Verona, Italy report.
University Of Wisconsin Reports Research In Thyroid CancerThyroid surgery is the mainstay of treatment for thyroid cancer, but there are options for the surgical approach. There is a general agreement that the goal of thyroid cancer surgery is to remove evident disease, minimize treatment and disease-related morbidity, minimize the risk of recurrence and metastatic spread, and facilitate long-term follow-up, scientists in the United States report.
IsoRay Announces It Has Provided Seeds To Canada For Research Initiatives To Expand The Use Of Cesium-131 For New Cancer ApplicationsIsoRay, Inc. announced that it has successfully shipped the first set of Cesium-131 brachytherapy seeds to a Canadian customer for the purpose of furthering research and development of Cesium-131 in Canada. Cesium-131 is currently approved by Health Canada for the treatment of low-risk prostate cancers and has been cleared by the US FDA for treatment of a wide variety of malignant disease (e.g. prostate, head and neck, brain, breast, lung, eye, etc.).
Research Describes The Role Of Spirituality In The Relationship Between Religiosity And Depression In Prostate Cancer PatientsResearchers detail in 'The role of spirituality in the relationship between religiosity and depression in prostate cancer patients,' new data in prostate cancer. This study aims to develop a theoretical framework of the relationship among religiosity, spirituality, and depression, potentially explaining the often mixed and inconsistent associations between religiosity and depression.
New Data From Mayo Clinic Illuminate Research In Colon CancerAccording to recent research from the United States, Genomics and proteomics have held out the promise of individualized medicine for the last 10 or 20 years, but clinical medicine has not yet delivered on this promise. Some cancers, such as breast cancer and some hematologic malignancies, have been at the forefront of individualized therapeutic approaches by integrating molecular biomarkers into treatment decision algorithms.
New Osteonecrosis Study Findings Have Been Published By Scientists At University Of BariOsteonecrosis of the jaws (ONJ) is a well known side effect of bisphosphonate therapies in patients with multiple myeloma or other malignancies. Its real incidence is still undetermined, and only few cases of ONJ in patients taking bisphosphonates for non- oncologic diseases have been reported, scientists writing in the Journal of Rheumatology report.
Cervical Cancer: Combined Drug And Radiotherapy Improves SurvivalCombining drugs and radiotherapy improves the survival chances of women receiving treatment for cervical cancer. These are the conclusions of Cochrane Researchers who carried out the most comprehensive study of the effects of combined drug and radiotherapy in cervical cancer treatment to date.
New Cervical Cancer Risk Factors Study Findings Have Been Reported From National Cancer CenterFresh data on cervical cancer are presented in the report 'Intakes of vitamin A, C, and E, and beta-carotene are associated with risk of cervical cancer: a case-control study in Korea.' Cervical cancer is one of the most common gynecological malignancies in Korea, although the incidence has been declining in recent years. This study explored whether antioxidant vitamin intakes influenced the risk of cervical cancer, researchers in Korea report.
Disarming Specialized Stem Cells Might Combat Deadly Ovarian CancerEliminating cancer stem cells (CSCs) within a tumor could hold the key to successful treatments for ovarian cancer, which has been notoriously difficult to detect and treat, according to new findings published this week in the journal Oncogene by Yale School of Medicine researchers.
Findings From University Of Texas M.D. Anderson Cancer Center, M.D. Anderson Cancer Center Provide New Insights Into Non-Small-Cell Lung CarcinomaScientists discuss in 'Expression of interleukin- 1 receptor-associated kinase-1 in non-small cell lung carcinoma and preneoplastic lesions' new findings in non-small-cell lung carcinoma. In this recent study, researchers in the United States conducted a study To identify the pattern of interleukin-1 receptor-associated kinase (IRAK-1) protein expression in non-small cell lung carcinoma (NSCLC) and corresponding preneoplastic lesions.
Physical Activity Associated With Healthier AgingPhysical activity appears to be associated with a reduced risk or slower progression of several age-related conditions as well as improvements in overall health in older age, according to a commentary and four articles published in the January 25 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Yale University: Women With Variants In 'Clock' Gene Have Higher Risk Of Breast CancerA Yale University-led team of researchers has demonstrated for the first time that variants in a gene responsible for regulating the body's circadian rhythm may lead to breast cancer. The study appears as an OnlineFirst publication of the journal Cancer Research.
Women With Breast Cancer May Benefit From Autologous Stem Cell TransplantationCompared to conventional chemotherapy, autologous stem cell transplantation can extend event-free survival for breast cancer patients. Clinical trials provide proof of this for breast cancer with and without distant metastases. However, there are indications that this type of stem cell transplantation can more frequently give rise to severe complications affecting almost all organ systems.
Research Describes Breast Cancer And Treatment For DepressionWomen taking tamoxifen for the treatment or prevention of recurrence of breast cancer are likely to take antidepressants either for a psychiatric disorder or for hot flashes. Recent evidence suggested that some antidepressants inhibit the metabolism of tamoxifen to its more active metabolites by the cytochrome P450 2D6 (CYP2D6) enzyme, thereby decreasing the anticancer effect, scientists in Montreal, Canada report.
Medifocus, Inc. Announces Food And Drug Administration FDA Update For Its Pivotal Phase III Clinical Trial For Treatment Of Breast Cancer: Files Response To Two Remaining QuestionsMedifocus, Inc. is pleased to announce that it has filed on January 22, 2010, its response to two (2) remaining questions with the FDA in the United States of America (USA) to obtain clearance to initiate a pivotal phase III clinical trial using the Company's Microfocus APA 1000 System for the treatment of breast cancer in the USA and worldwide.
